Ross Brooks


Sanford Heisler LLP

Ross Brooks, co-chair of Sanford Heisler’s whistleblower practice, represents whistleblowers in actions brought under the False Claims Act (“FCA”), the Dodd-Frank Wall Street Reform and Consumer Protection Act, and the IRS Whistleblower Law, among other whistleblower statutes. Throughout his career, Mr. Brooks has participated in the recovery of hundreds of millions in defrauded funds on behalf of the government. Notably, he was counsel to the plaintiffs in United States ex rel. Silva v. Amgen, 08-cv-04157 (E.D. Pa.)($762 million intervened settlement of claims against pharmaceutical manufacturer arising from unlawful marketing and kickbacks paid to physicians to induce purchases of anemia drugs); United States ex rel. Gale v. Omnicare, 10-cv-0127 (N.D. Ohio)($116 million non-intervened settlement of claims against long-term care pharmacy arising from unlawful kickbacks paid to nursing homes to induce drug purchases); and United States ex rel. Gipson et al. v. Pathway Genomics Corporation, 14-cv-01919 (S.D. Cal.)($4.1 million settlement of claims against genetic testing manufacturer arising from unlawful kickbacks paid to physicians to induce purchases of generic testing products). In addition to guiding relators through qui tam litigation, Mr. Brooks  represents governmental entities, labor unions, and individuals in consumer fraud class actions and other civil litigation.  He earned his undergraduate degree at Cornell University and his law degree at The University of Chicago Law School.